Visgenx Announces Presentation of Data Supporting Potential of its Synthetic AAV DNA Platform for Gene Editing at ASGCT
Data demonstrate Synthetic AAV genome platform offers promising gene editing alternative to CRISPR based methods due to enhanced safety profile and precision SAN DIEGO, CALIFORNIA, USA, May 9, 2024 /EINPresswire.com/ -- Visgenx, Inc., a …